Novo Nordisk A/S

Healthcare

NYSE:NVO · New York Stock Exchange

Market Cap $196.82B Beta 0.35 P/E (TTM) 10.5

$44.29 +0.75%

+$0.33 today

52W Low $35.12High $81.44

Vol 10.16M · Avg 16.14M

EPS (TTM)$27.45

Div Yield4.07%

Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-43.61%

Period High

$78.36

Period Low

$35.17

Latest

$44.19

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Merck & Co., Inc.

NYSE:MRK

$296.18B

Novartis AG

NYSE:NVS

$292.74B

AstraZeneca PLC

NYSE:AZN

$278.85B

Amgen Inc.

NASDAQ:AMGN

$190.79B

Thermo Fisher Scientific Inc.

NYSE:TMO

$174.66B

Gilead Sciences, Inc.

NASDAQ:GILD

$155.57B

Abbott Laboratories

NYSE:ABT

$152.81B

Pfizer Inc.

NYSE:PFE

$149.27B

GSK plc

NYSE:GSK

$106.58B

Sanofi

NASDAQ:SNY

$106.52B

What is the latest NVO filing?

The latest filing shown is 6-K dated Jun 8, 2026.

How many recent filings does NVO have?

Intrinsic Alpha currently shows 20 recent filings for NVO.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.